Among US postmenopausal women, the use of oral estrogen generally and vaginally administered estrogen products declined in age groups <65 years between 2006 and 2015, a recent study found. Researchers used prescription claims for US commercial health insurance to calculate, in women aged ≥50 years (n=12,007,364), the age-standardized and age-specific annual prevalence of estrogen use by formulation and route of administration during the specified study period. They found:
- The age-standardized annual prevalence of a prescription claim for oral estrogens declined over time, from 83 per 1,000 women in 2007 to 42 per 1,000 women in 2015.
- The age-standardized annual prevalence of a prescription claim for vaginal estrogens peaked in 2011, at 42 per 1,000 women, before declining to 35 per 1,000 women in 2015.
- The age-standardized annual prevalence of a prescription claim for transdermal estrogen fluctuated between 15 and 17 per 1,000 women.
- Annual prevalence rates for vaginal rings and inserts declined over the latter half of the study period in age groups <65 years.
Weissfeld JL, Liu W, Woods C, et al. Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance. [Published online ahead of print December 28, 2017]. Menopause. doi:10.1097/GME.0000000000001054.
This Week's Must Reads
Second-Stage Duration & Outcomes After Prior CD, Obstet Gynecol; ePub 2018 Feb 5; Hehir, et al
Antihypertensive Med Use to Treat Preeclampsia, Obstet Gynecol; ePub 2018 Feb 5; Cleary, et al
Self-Reporting Hormonal Contraceptive Use & HIV, Contraception; ePub 2018 Feb 2; Pyra, et al
Cancer Tx and Infertility Risk in Women with PCOS, Fertil Steril; ePub 2018 Feb 7; Shandley, et al
ACOG Offers Guidance on Management of GDM, Obstet Gynecol; ePub 2018 Feb; ACOG, Turrentine
Must Reads in Menopause
Effect of Hormone Therapy on Incident Hypertension , Menopause; ePub 2018 Jan 29; Swica, et al
Impact of PCOS on Menopausal Symptoms Evaluated, Menopause; ePub 2018 Jan 22; Yin, et al
Trends in Estrogen Use Among US Women, Menopause; ePub 2017 Dec 28; Weissfeld, et al
CV and Metabolic Morbidity After Hysterectomy, Menopause; ePub 2017 Dec 28; Laughlin-Tommaso, et al
USPSTF Guidelines for HT in Postmenopausal Women, JAMA; 2017 Dec 12; US Preventive Services Task Force